✦ LIBER ✦

PCN12 BUDGETARY IMPACT OF XELOX IN COLORECTAL CANCER IN ITALY

✍ Scribed by MC Nuijten; G Giuliani; Vulpillières F de Reydetde

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN35 Capecitabine for the Treatment of

✍ Clark, O.; Clark, L.G.O.; Botrel, T.E.A.; Paladini, L.; Medina, P.; Rosa, B.; Fi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Two Doses of Oxaliplatin with Capecitabi

✍ Isabel Moreno-Solórzano; Rafael Ibeas-Rollan; Mariano Monzó-Planella; José Moren 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 116 KB

PCN110 COST-MINIMIZATION ANALYSIS OF XEL

✍ AS Zazaa; H AlOmar; SA El-Moursy; M AlFayyadh 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PCN12 COLORECTAL CANCER: COST-EFFECTIVEN

✍ JW Coffindaffer; LA Miller; M Auber; A Jacknowitz; V Scott 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

PCN21 TREATMENT COST OF COLORECTAL CANCE

✍ K Hieke; A Grothey 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PCN22 Safety Profile of Bevacizumab in M

✍ Castillo, M.A.; Ubago, R.; Flores, S.; Rodríguez, R.; Beltrán, C. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB